Clinical Trials

Aperion Biologics, Inc. is conducting a multi-center, randomized clinical trial in the EU and S. Africa to investigate the use of the Z-Lig^® compared to allograft for the reconstruction of ruptured ACLs. For information on the clinical trial and participating countries, please visit: www.clinicaltrials.gov

If you are interested in becoming a clinical investigator for this study, please contact Sandra Navarrete, Clinical Affairs Manager at: snavarrete@aperionbiologics.com

©2009 Aperion Biologics Corporation. All rights reserved. Privacy policy. Access to and use of this Web site is subject to these Terms of Use.